Addressing Doubts on the Hepatitis B Vaccine's Safety
Recently, Health and Human Services Secretary Robert F. Kennedy Jr., along with his newly chosen vaccine advisory committee, have been questioning the standard practice of immunizing newborns against hepatitis B.
During their initial gathering at the CDC's Advisory Committee on Immunization Practices (ACIP), concerns were raised by the chair about the prudence of administering vaccines to infants before hospital discharge.
Martin Kulldorff, once affiliated with Harvard Medical School, mentioned that a newly formed discussion group would examine this vaccination strategy.
Kennedy's Unsubstantiated Claims
In an interview with Tucker Carlson, Kennedy alleged, without providing proof, that the CDC carried out a study indicating an increased autism risk from the hepatitis B vaccine which was supposedly concealed from public knowledge.
Requests by ABC News to the HHS for access to the study Kennedy mentioned went unmet.
An expert in infectious diseases stated to ABC News there exists no evidence implicating the hepatitis B vaccine in safety concerns, highlighting the critical role of newborn vaccination in nearly eliminating pediatric hepatitis B infections.
Understanding Hepatitis B
Per the CDC, hepatitis B involves a liver infection triggered by the hepatitis B virus, typically contracted through contact with the bodily fluids of an infected person.
Dr. Peter Chin-Hong from the University of California, San Francisco, explained that newborns can contract the virus at birth or through everyday interactions, as the virus survives for up to a week in the environment.
Approximately 50% of older children, teenagers, and adults with sudden onset hepatitis B exhibit symptoms, whereas most young children under age five do not, according to CDC data.
"Hepatitis B causes liver inflammation," stated Chin-Hong, "which can result in cirrhosis, liver failure, or even cancer over time if left untreated."
The CDC notes that acute hepatitis B, a short-term illness, may evolve into chronic hepatitis B, posing long-term health risks.
Chin-Hong emphasized that early infection or being born with the virus notably raises the odds of severe liver-related health issues in later life.
The Value of Vaccination
Chin-Hong mentioned vaccination as the most effective strategy to prevent hepatitis B, with vaccines commonly administered in either two or three-shot series depending on the brand.
Current guidelines advise administering the first dose of the vaccine shortly after birth, a second dose at one to two months, and a possible third dose between six to fifteen months of age.
Chin-Hong remarked, "Receiving all three doses boosts the vaccine's effectiveness above 97%," underscoring the immunization's robust protection.
The practice initiated in 1991 to curtail virus spread in children resulted in a steep decline in cases—from 18,000 infections in under-10s nationwide to below 0.1 per 100,000 among under 19s by 2022, according to CDC data.
Chin-Hong concluded, "The initiative's success story serves as a global benchmark, justifying infant hepatitis B vaccination and transforming liver health outcomes worldwide."
Safety Confirmation of Hepatitis B Vaccination
The ACIP meeting featured remarks by Kulldorff comparing the contemporary vaccine schedule with past practices.
"Today's children receive more vaccines than previous generations or their peers in other developed nations," Kulldorff noted.
Chin-Hong highlighted advancements in vaccine technology, including decreased antigen exposure through subunit vaccines, offering enhanced protection with minimal viral or bacterial elements.
Chin-Hong outlined potential misconceptions concerning the reassessment of vaccines like hepatitis B by the ACIP as undermining their prior endorsement.
Addressing Kennedy's assertions, HHS Secretary Kennedy has long been skeptical of vaccines, even refraining from disavowing a vaccine-autism link at his confirmation hearings despite substantial contradictory evidence.
"No credible research supports the notion of a link between the hepatitis B vaccine and autism," Chin-Hong firmly stated.



Leave a Reply